Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Textron
TXT
$14.1B
| $28.9M | 0.05% |
647,241
-893,610
| -58% | -$40.6M |
|
452
Viatris
VTRS
$18.9B
| $28.9M | 0.05% |
425,182
-660,800
| -61% | -$46.7M |
|
453
Forum Energy Technologies
FET
$860M
| $28.8M | 0.05% |
71,061
-55,797
| -44% | -$23.9M |
|
|
MRSH
454
Marsh
MRSH
$92.5B
| $28.8M | 0.05% |
507,446
-369,612
| -42% | -$21.3M |
|
|
CLDT
455
Chatham Lodging
CLDT
$637M
| $28.7M | 0.05% |
1,084,518
+104,911
| +11% | +$2.95M |
|
456
BioCryst Pharmaceuticals
BCRX
$2.47B
| $28.6M | 0.05% |
1,917,021
-514,102
| -21% | -$5.84M |
|
457
Motorola Solutions
MSI
$79.6B
| $28.6M | 0.05% |
499,000
+382,634
| +329% | +$22.9M |
|
|
AEGR
458
DELISTED
Aegerion Pharmaceuticals
AEGR
| $28.5M | 0.05% |
1,502,443
+406,206
| +37% | +$8.79M |
|
459
Nelnet
NNI
$4.57B
| $28.5M | 0.05% |
657,195
+61,072
| +10% | +$2.68M |
|
|
GIMO
460
DELISTED
Gigamon Inc.
GIMO
| $28.5M | 0.05% |
862,746
+83,030
| +11% | +$2.45M |
|
461
First Horizon
FHN
$11.7B
| $28.5M | 0.05% |
1,815,921
-158,435
| -8% | -$2.34M |
|
462
Prothena Corp
PRTA
$484M
| $28.4M | 0.05% |
539,913
-198,516
| -27% | -$7.83M |
|
463
PUT
Vale
VALE
$63.7B
| $28.3M | 0.05% |
4,808,000
+3,606,300
| +300% | +$24.1M |
|
464
Oceaneering
OII
$5.02B
| $28.2M | 0.05% |
606,095
+233,375
| +63% | +$12.3M |
|
|
ZSPH
465
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $28.2M | 0.05% |
538,618
+450,142
| +509% | +$22.2M |
|
466
Cracker Barrel
CBRL
$1.3B
| $28.2M | 0.05% |
188,985
+53,554
| +40% | +$7.63M |
|
467
Ryder
R
$9.38B
| $28.1M | 0.05% |
322,165
+151,447
| +89% | +$14.3M |
|
468
Regal Rexnord
RRX
$10.8B
| $28.1M | 0.05% |
387,551
-103,914
| -21% | -$8.03M |
|
469
Vornado Realty Trust
VNO
$7.26B
| $28.1M | 0.05% |
366,072
+66,525
| +22% | +$5.52M |
|
|
SGY
470
DELISTED
Stone Energy
SGY
| $28M | 0.05% |
39,134
+34
| +0.1% | +$28.9K |
|
471
L3Harris
LHX
$48.8B
| $28M | 0.05% |
363,930
-2,888
| -0.8% | -$229K |
|
472
CALL
BP
BP
$113B
| $28M | 0.05% |
+831,472
| New | +$29.1M |
|
473
Allegion
ALLE
$13.8B
| $27.9M | 0.05% |
464,009
+380,601
| +456% | +$23.3M |
|
474
FedEx
FDX
$78B
| $27.8M | 0.05% |
163,369
-162,656
| -50% | -$28.3M |
|
475
Westlake Corp
WLK
$9.74B
| $27.7M | 0.05% |
403,141
-494,012
| -55% | -$35.9M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.